Therapeutic potential of propranolol in central nervous system disorders
Abstract
Introduction: Propranolol (Prop), a classic non-selective β-adrenergic receptor antagonist, has long played a significant role in the treatment of cardiovascular diseases such as hypertension and arrhythmias. Compared with its peripheral regulatory effects, the potential therapeutic value of Prop in neurological disorders such as post-traumatic stress disorder (PTSD), memory dysfunction, autism spectrum disorder (ASD), anxiety, migraine prophylaxis, and essential tremor is gradually being re-evaluated.
Methods: This review aims to integrate the latest evidence from clinical and preclinical studies, systematically reviewing the effects of Prop on neurological diseases and its potential mechanisms.
Results: Specifically, we explore its translational value from the perspective of β-adrenergic receptor subtype-specific regulation, thereby assessing its potential for precision medicine in neurology.
Discussion: Finally, this review outlines novel therapeutic strategies targeting β receptors for treating central nervous system (CNS) diseases, with the ultimate goal of providing a robust theoretical foundation and clear translational pathways for future drug development.
Read the paper
Related studies
- Diarylethenes for Memories and Switches
- Long-Term Potentiation and Memory
- Social Memory Studies: From “Collective Memory” to the Historical Sociology of Mnemonic Practices
- The Cognitive Neuroscience of Working Memory
- Memory aging and brain maintenance
- Effector and Memory CTL Differentiation
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.